Ingevity Corporation (NGVT) Q4 FY25 Earnings Call

Strong cash generation and portfolio actions offset weak markets, but 2026 guidance includes limited macro recovery and a $95 million litigation payment [40][41].

Q4 FY25 results, source: company transcript and SEC filings
QuarterQ4 FY25
Call date2026-02-27
Length41 minutes
EPS$0.58
EPS consensus$0.74
Revenue$333.1M
Revenue consensus$257.3M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

All NGVT earnings ยท Back to NGVT overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.